Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and Sorafenib in Metastatic Renal Cell Carcinoma
NCT01100242Phase 2Terminated
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Apr 2010
- Primary completion
- Jan 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in renal cell carcinoma (RCC), sponsored by New Mexico Cancer Research Alliance. Started Apr 2010; status: terminated.
02
Drugs
bortezomib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01100242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100242.